MAGROLIMAB
UNII 90YIEHRFJ9

Substance Identification & Data

This profile provides standardized clinical and technical data for Magrolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 90YIEHRFJ9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2169232-81-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
90YIEHRFJ9
CAS Registry Number
2169232-81-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MAGROLIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C117730
National Cancer Institute reference terminology for clinical and research data.
INN ID
10999
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
HI-132
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Magrolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MAGROLIMAB

Common Names & Synonyms

ANTI-CD47 MONOCLONAL ANTIBODY HU5F9-G4
MAGROLIMAB [INN]
MAGROLIMAB [USAN]
MAGROLIMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4(225-PROLINE), ANTI-(HUMAN CD47 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HU5F9-G4 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HU5F9-G4 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CD47 (INTEGRIN ASSOCIATED PROTEIN, IAP, MER6, OA3)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV1-3*01 (87.8%)-(IGHD)-IGHJ4*01 (100%)) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (CH1 (118-215), HINGE S10>P (225) (216-227), CH2 (228-337), CH3 (338-442), CHS (443-444)) (118-444)), (131-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (V-KAPPA (MUS MUSCULUS IGKV1-117*01 (89.0%)-IGKJ2*03 (91.7%)/HOMO SAPIENS IGKV2-28*01 (86%)-IGKJ2*01 (100%)) (11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219'))DIMER (223-223'':226-226'')-BISDISULFIDE

Technical Codes

HU5F9-G4

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus